Recent advances in fertility preservation and counseling for female cancer patients

References

• Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistic. CA Cancer J Clin. 2016;66:271–289.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Fertility preservation in women. Nat Rev Endocrinol. 2013;9:735–749.
   PubMed Web of Science ®Google Scholar
• Letourneau JM, Ebbel EE, Katz PP, et al. Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012;118:1710–1717.
   PubMed Web of Science ®Google Scholar
• Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6:922.
   Web of Science ®Google Scholar
• Jadoul P, Dolmans MM, Donnez J. Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? Hum Reprod Update. 2010;16:617–630.
   PubMed Web of Science ®Google Scholar
• Barton SE, Najita JS, Ginsburg ES, et al. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol. 2013;14:873–881.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017;377:1657–1665.
   PubMed Web of Science ®Google Scholar
• Logan S, Perz J, Ussher J, et al. Clinician provision of oncofertility support in cancer patients of a reproductive age: a systematic review. Psychooncology. 2017. [Epub ahead of print].
   Google Scholar
• Chung JP, Lao TT, Li TC. Evaluation of the awareness of, attitude to, and knowledge about fertility preservation in cancer patients among clinical practitioners in Hong Kong. Hong Kong Med J. 2017. [Epub ahead of print].
   Google Scholar
• McCracken K, Nahata L. Fertility preservation in children and adolescents: current options and considerations. Curr Opin Obset Gynecol. 2017;29:283-288. [Epub ahead of print].
   Google Scholar
• Donnez J, Martinez-Madrid B, Jadoul P, et al. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update. 2006;12:519–535.
   PubMed Web of Science ®Google Scholar
• De Vos M, Smitz J, Woodruff TK. Fertility preservation in women with cancer. Lancet. 2014;384:1302–1310.
   PubMed Web of Science ®Google Scholar
• Loren AW, Mangu PB, Beck LN, et al. American Society of Clinical Oncology. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500–2510.
   PubMed Web of Science ®Google Scholar
• Ethics Committee of American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertil Steril. 2013;100:1224–1231.
   PubMed Web of Science ®Google Scholar
• Moore HC, Unger JM, Phillips KA, et al. POEMS/S0230 Investigators. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;5(372):923–932.
   Google Scholar
• Demeestere I, Brice P, Peccatori FA, et al. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol. 2016;34:2568–2574.
   PubMed Web of Science ®Google Scholar
• Rienzi L, Gracia C, Maggiulli R, et al. embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. J Assist Reprod Genet. 2015;32:1195–1196.
   PubMed Web of Science ®Google Scholar
• Rienzi L, Ubaldi FM. Oocyte versus embryo cryopreservation for fertility preservation in cancer patients: guaranteeing a women’s autonomy. Hum Reprod Update. 2017;23:139–155.
   PubMed Web of Science ®Google Scholar
• Cobo A, García-Velasco JA, Coello A, et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril. 2016;105:755–764.
   PubMed Web of Science ®Google Scholar
• Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013;99:1476–1484.
   PubMed Web of Science ®Google Scholar
• Vaiarelli A, Venturella R, Vizziello D, et al. Dual ovarian stimulation and random start in assisted reproductive technologies: from ovarian biology to clinical application. Curr Opin Obstet Gynecol. 2017;29:153–159.
   PubMed Web of Science ®Google Scholar
• Dolmans MM, Hollanders de Ouderaen S, Demylle D, et al. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment. J Assist Reprod Genet. 2015;32:1233–1237.
   PubMed Web of Science ®Google Scholar
• Cardozo ER, Thomson AP, Karmon AE, et al. Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience. J Assist Reprod Genet. 2015;32:587–596.
   PubMed Web of Science ®Google Scholar
• Wallace WH, Smith AG, Kelsey TW, et al. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014;15:1129–1136.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM, Demylle D, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:2020.
   PubMed Web of Science ®Google Scholar
• Greve T, Schmidt KT, Kristensen SG, et al. Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue. Fertil Steril. 2012;97:1394–1398.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM, Diaz C, et al. Ovarian cortex transplantation: time to move on from experimental studies to open clinical application. Fertil Steril. 2015;104:1097–1098.
   PubMed Web of Science ®Google Scholar
• Meirow D, Ra’anani H, Shapira M, et al. Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria. Fertil Steril. 2016;106:467–474.
   PubMed Web of Science ®Google Scholar
• Jadoul P, Guilmain A, Squifflet J, et al. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases. Hum Rep. 2017;32:1046–1054.
   PubMed Web of Science ®Google Scholar
• Dolmans MM, Marotta ML, Pirard C, et al. Ovarian tissue cryopreservation followed by controlled ovarian stimulation and pick-up of mature oocytes does not impair the number or quality of retrieved oocytes. J Ovarian Res. 2014;7:80.
   PubMed Web of Science ®Google Scholar
• Bedoschi G, Oktay K. Current approach to fertility preservation by embryo cryopreservation. Fertil Steril. 2013;99:1496–1502.
   PubMed Web of Science ®Google Scholar
• Gorman JR, Su HI, Roberts SC, et al. Experiencing reproductive concerns as a female cancer survivor is associated with depression. Cancer. 2015;121:935–942.
   PubMed Web of Science ®Google Scholar
• Deshpande NA, Braun IM, Meyer FL. Impact of fertility preservation counseling and treatment on psychological outcomes among women with cancer: a systematic review. Cancer. 2015;121:3938–3947.
   PubMed Web of Science ®Google Scholar
• Hariton E, Bortoletto P, Cardozo ER, et al. The role of oncofertility clinics in facilitating access to reproductive specialists. J Patient Exp. 2016;3:131–136.
   PubMedGoogle Scholar
• Keim-Malpass J, Fitzhugh HS, Smith LP, et al. What is the role of the oncology nurse in fertility preservation counseling and education for young patients? J Cancer Educ. 2017. [Epub ahead of print].
   PubMedGoogle Scholar
• Bradford NK, Walker R, Henney R, et al. Improvements in clinical practice for fertility preservation among young cancer patients: results from bundled interventions. J Adolesc Young Adult Oncol. 2017. [Epub ahead of print].
   Google Scholar
• Ehrbar V, Urech C, Rochlitz C, et al. Fertility preservation in young female cancer patients: development and pilot testing of an online decision aid. J Adolesc Young Adult Oncol. 2017. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Cardozo ER, Huber WJ, Stuckey AR, et al. Mandating coverage for fertility preservation – a step in the right direction. N Engl J Med. 2017;377:1607–1609.
   PubMed Web of Science ®Google Scholar
• Jones G, Hughes J, Mahmoodi N, et al. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment? Hum Reprod Update. 2017;23:433–457.
   PubMed Web of Science ®Google Scholar
• Walter JR, Xu S, Woodruff TK. A call for fertility preservation coverage for breast cancer patients: the cost of consistency. J Natl Cancer Inst. 2017;109:5.
   PubMedGoogle Scholar
• Salama M, Woodruff TK. Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice. Expert Rev Anticancer Ther. 2017;17:687–692.
   PubMed Web of Science ®Google Scholar
• Letourneau JM, Sinha N, Wald K, et al. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer. Hum Reprod. 2017;32:2123–2129.
   PubMed Web of Science ®Google Scholar
• Ubaldi FM, Capalbo A, Vaiarelli A, et al. Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation. Fertil Steril. 2016;105:1488–1495.
   PubMed Web of Science ®Google Scholar
• Tsampras N, Gould D, Fitzgerald CT. Double ovarian stimulation (DuoStim) protocol for fertility preservation in female oncology patients. Hum Fertil (Camb). 2017;20:248-253.
   Web of Science ®Google Scholar
• Dolmans MM, Marinescu C, Saussoy P, et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116:2908–2914.
   PubMed Web of Science ®Google Scholar
• Greve T, Clasen-Linde E, Andersen MT, et al. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells. Blood. 2012;120:4311–4316.
   PubMed Web of Science ®Google Scholar
• Amorim CA, Shikanov A. The artificial ovary: current status and future perspectives. Future Oncol. 2016;12:2323–2332.
   PubMed Web of Science ®Google Scholar
• Soares M, Saussoy P, Maskens M, et al. Eliminating malignant cells from cryopreserved ovarian tissue is possible in leukaemia patients. Br J Haematol. 2017;178:231–239.
   PubMed Web of Science ®Google Scholar
• Telfer EE, Zelinski MB. Ovarian follicle culture: advances and challenges for human and nonhuman primates. Fertil Steril. 2013;99:1523–1533.
   PubMed Web of Science ®Google Scholar
• Demeestere I, Simon P, Emiliani S, et al. Orthotopic and heterotopic ovarian tissue transplantation. Hum Reprod Update. 2009;15:649–665.
   PubMed Web of Science ®Google Scholar
• Dolmans MM, Binda MM, Jacobs S, et al. Impact of the cryopreservation technique and vascular bed on ovarian tissue transplantation in cynomolgus monkeys. J Assist Reprod Genet. 2015;32:1251–1262.
   PubMed Web of Science ®Google Scholar
• Manavella DD, Cacciottola L, Desmet CM, et al. Adipose tissue-derived stem cells  in a fibrin implant enhance neovascularization in a peritoneal grafting site:  a potential way to improve ovarian tissue transplantation. Hum Reprod. Accepted 2017.
   Google Scholar
• Jensen AK, Macklon KT, Fedder J, et al. 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children. J Assist Reprod Genet. 2017;34:325–336.
   PubMed Web of Science ®Google Scholar
• Massarotti C, Scaruffi P, Lambertini M, et al. State of the art on oocyte cryopreservation in female cancer patients: a critical review of the literature. Cancer Treat Rev. 2017;57:50–57.
   PubMed Web of Science ®Google Scholar
• Cobo A, Serra V, Garrido N, et al. Obstetric and perinatal outcome of babies born from vitrified oocytes. Fertil Steril. 2014;102:1006–1101.
   PubMed Web of Science ®Google Scholar
• Levi Setti PE, Porcu E, Patrizio P, et al. Human oocyte cryopreservation with slow freezing versus vitrification. Results from the National Italian Registry data, 2007-2011. Fertil Steril. 2014;102:90–95.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Wallberg KA, Tanbo T, Tinkanen H, et al. Ovarian tissue cryopreservation and transplantation among alternatives for fertility preservation in the Nordic countries – compilation of 20 years of multicenter experience. Acta Obstet Gynecol Scand. 2016;95:1015–1026.
   PubMed Web of Science ®Google Scholar
• Yee S. Factors associated with the receipt of fertility preservation services along thedecision-making pathway in young Canadian female cancer patients. J Assist Reprod Genet. 2016;33:265–280.
   PubMed Web of Science ®Google Scholar
• Anckaert E, De Rycke M, Smitz J. Culture of oocytes and risk of imprinting defects. Hum Reprod Update. 2013;19:52–66.
   PubMed Web of Science ®Google Scholar
• Saenz-de-Juano MD, Billooye K, Smitz J, et al. The loss of imprinted DNA methylation in mouse blastocysts is inflicted to a similar extent by in vitro follicle culture and ovulation induction. Mol Hum Reprod. 2016;22:427–441.
   PubMed Web of Science ®Google Scholar